<DOC>
	<DOCNO>NCT02328625</DOCNO>
	<brief_summary>This registry study assess safety performance Celution Device process autologous graft consist adipose derive regenerative cell ( ADRCs ) treatment hand scleroderma .</brief_summary>
	<brief_title>Scleroderma Treatment With Celution Processed ADRCs Registry</brief_title>
	<detailed_description>This registry study assess safety performance Celution System preparation adipose derive regenerative cell treatment scleroderma affect hand . This multi-center , multi-national study .</detailed_description>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Scleroderma , Localized</mesh_term>
	<criteria>Diagnosis scleroderma presence hand scleroderma Cochin score ≥ 20 unit Body Mass Index &lt; 17 kg/m2 Infection finger Stable medication treatment scleroderma ≥ 1 month Pregnant lactating status .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Scleroderma</keyword>
	<keyword>Device</keyword>
	<keyword>ADRCs</keyword>
	<keyword>adipose derive regenerative cell</keyword>
	<keyword>hand</keyword>
</DOC>